help button home button Am J Pathol R & D Systems
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Order Full text via Infotrieve
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Dickson, D. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dickson, D. W.

American Journal of Pathology, Vol 151, 7-11, Copyright © 1997 by American Society for Investigative Pathology

REVIEWS

Discovery of new lesions in neurodegenerative diseases with monoclonal antibody techniques: is there a non-amyloid precursor to senile plaques?

DW Dickson
Department of Pathology, Albert Einstein College of Medicine, Bronx, New York 10461, USA.

The manuscript by Schmidt et al reports that antibodies generated to paired helical filaments (AMY antibodies) unexpectedly labeled novel non-amyloid, plaque-like structures (AMY plaques) in aged and Alzheimer's disease brains. The full disclosure of the nature of these lesions awaits additional structural and biochemical studies, but at first glance there are interesting parallels between AMY plaques and recently described lesions composed of glia and glia-associated proteoglycans in brains of aged mice. The increasing recognition of the role of proteoglycans in paired helical filaments formation makes proteoglycans or their associated molecules attractive candidates for AMY-immunoreactive proteins. The relationship of AMY plaques to age- related glial changes that some have speculated may be precursors to senile plaques remains to be determined, as is the relationship of AMY plaques to more widely recognized amyloid-containing plaques. Future studies will determine whether AMY plaques are non-amyloid precursors to senile plaques or if they represent an independent type of structural lesion in the Alzheimer's disease brain. Ultimately, the clinical significance of AMY plaques will depend upon their characterization in brains of prospectively studied subjects.


This article has been cited by other articles:


Home page
 Am. J. Pathol.Home page
C. A. Lemere, T. J. Grenfell, and D. J. Selkoe
The AMY Antigen Co-Occurs with A{beta} and Follows Its Deposition in the Amyloid Plaques of Alzheimer's Disease and Down Syndrome
Am. J. Pathol., July 1, 1999; 155(1): 29 - 37.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1997 by the American Society for Investigative Pathology.